Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...

American importers have been stockpiling the popular Italian bubbly Prosecco as a hedge against the possible impact of ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Q3 2025 Earnings Conference Call February 7, 2025 11:00 AM ETCompany ParticipantsTom Cook - Managing Director, ICRDan Thoren ...

The upgrade is based on Moody's expectation of robust earnings growth for Eli Lilly in the coming years. This growth is anticipated to be driven by the company's incretin portfolio, which includes ...

Canada’s Trans Mountain oil pipeline, which allows producers to sell crude to markets in Asia, could fill to capacity as ...

Victory Capital Holdings Limited ( NASDAQ: VCTR) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET David Brown - Chairman, Chief Executive Officer Michael Pilicarpo - President, Chief ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...